BioSyndexBioSyndex

For accredited investors

Vetted biopharma deals, inside clean SPVs.

Reg D 506(c) only. After verification, review opportunities matched to your focus and co-invest alongside people you trust — through a ring-fenced SPV with liability capped at your commitment. Free to participate, always.

Regulatory notice

This opportunity is only visible to verified accredited investors under Rule 506(c) of Regulation D.

  • Curated, accredited-only flow
  • One SPV per deal (limited liability, pro-rata rights, one K-1)
  • Precision Diligence synthesis on every published deal
Request accessI'm raising capital

Accredited investor policy · Already approved? Sign in

How it works

  1. 1. Verify accreditation (506(c))
  2. 2. Review matched, diligence-backed deals
  3. 3. Commit through the deal's SPV
Request access

Read the full lifecycle →

Request early access

Join the invite-only beta waitlist. We review strategic fit to protect syndicate quality.

By submitting, you agree BioSyndex, Inc. may contact you about early access and related updates. See Privacy Policy and Terms of Use.

Newsletter

Occasional notes on SPV syndication, Precision Diligence, and platform updates—no spam.

By subscribing, you agree that BioSyndex, Inc. may send you marketing emails about BioSyndex. You can unsubscribe anytime via the link in each email (CAN-SPAM compliant opt-out). See our Privacy Policy.